INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jun 5, 2026
Page 710 of 1724
← PrevNext →
Jun 5, 2026
traded Jun 5, 2026
+0d
SEC Form 4

Evidence

0
VJ
Viana Antonio JDirector
AIPArteris, Inc.
Gift · 10b5-1 plan
G—
20.8K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

0
PM
Persky MarlaDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award · 10b5-1 plan
A—
24.2K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M—
8,064 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

0
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$900
100 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
PM
Persky MarlaDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award · 10b5-1 plan
A$203K
33.0K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M$40K
8,064 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

60
HC
Hochman Russell C.Director, President and CEO
NVRIEnviri Corp
Open-market purchase
BUY$1.00M
51.5K sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

54
KS
Katz Mark StephenEVP & General Counsel
RYANRYAN SPECIALTY HOLDINGS, INC.
Open-market purchase
BUY$100K
3,215 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

54
HM
Hamilton Janice MChief Financial Officer
RYANRYAN SPECIALTY HOLDINGS, INC.
Open-market purchase
BUY$200K
6,300 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

54
CC
Cueto Riestra Juan CarlosVP NEW BUSINESS CENTRAL REGION
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$255K
74.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

53
BK
Bartels Laura KathleenChief Accounting Officer
ARMARM HOLDINGS PLC /UK
Open-market sale
SELL$4.44M
11.3K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

53
PM
Purvis Edgar M JrDirector
NVRIEnviri Corp
Open-market purchase
BUY$253K
14.0K sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

50
BA
Biewald Lukas AlexanderDirector
XMTRXometry, Inc.
Open-market purchase
BUY$4.00M
47.1K sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

46
SF
Sottil Achutegui Juan FelipeCHIEF FINANCIAL OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$511K
148.7K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

44
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$1.02M
6,400 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

40
FA
Foglia Stephanie Athena10% Owner
MGMistras Group, Inc.
Open-market sale
SELL$16K
1,000 sh
Mar 3, 2026Jun 4, 2026
traded Mar 3, 2026
+93dSEC Form 4

Evidence

40
FA
Foglia Stephanie Athena10% Owner
MGMistras Group, Inc.
Open-market sale
SELL$14K
1,000 sh
Jan 5, 2026Jun 4, 2026
traded Jan 5, 2026
+150dSEC Form 4

Evidence

40
FA
Foglia Stephanie Athena10% Owner
MGMistras Group, Inc.
Open-market sale
SELL$18K
1,000 sh
Apr 17, 2026Jun 4, 2026
traded Apr 17, 2026
+48dSEC Form 4

Evidence

40
FA
Foglia Stephanie Athena10% Owner
MGMistras Group, Inc.
Open-market sale
SELL$15K
1,000 sh
Feb 3, 2026Jun 4, 2026
traded Feb 3, 2026
+121dSEC Form 4

Evidence

39
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market purchase
BUY$224K
10.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

39
GR
Gupta RaviDirector, 10% Owner
CARTMaplebear Inc.
Open-market sale
SELL$7.51M
181.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

39
VF
Vahaviolos Aspasia Felice10% Owner
MGMistras Group, Inc.
Gift
G—
528.7K sh
Dec 31, 2025Jun 4, 2026
traded Dec 31, 2025
+155dSEC Form 4

Evidence

37
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$747K
4,795 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

37
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$457K
2,900 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

37
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$523K
3,300 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

37
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$866K
5,530 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

36
SF
Sottil Achutegui Juan FelipeCHIEF FINANCIAL OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$4,634
1,347 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

36
AG
Ackermann Cathy GDirector
SMBKSMARTFINANCIAL INC.
Open-market purchase
BUY$126K
3,000 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

36
NT
Notman TaliCHIEF REVENUE OFFICER
FROGJFrog Ltd
Open-market sale
SELL$1.98M
22.9K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

35
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
200 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

35
MP
McCuen Michael PEVP/Chief Banking Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale
SELL$98K
5,250 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

35
HP
Henry John P. IVDirector
JUVFJUNIATA VALLEY FINANCIAL CORP
Open-market purchase
BUY$1,443
100 sh
Jun 1, 2026Jun 4, 2026
traded Jun 1, 2026
+3dSEC Form 4

Evidence

33
HP
Henry John P. IVDirector
JUVFJUNIATA VALLEY FINANCIAL CORP
Open-market purchase
BUY$13K
900 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

33
SH
Shlomi Ben HaimDirector, CHIEF EXECUTIVE OFFICER
FROGJFrog Ltd
Open-market sale
SELL$3.73M
43.1K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

32
ST
Sharp Richard TroyChief Accounting Officer
DELLDell Technologies Inc.
Open-market sale
SELL$570K
1,300 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

32
CS
Crowe SuzanneDirector
RCELAVITA Medical, Inc.
Grant or award
A—
22.2K sh
Jan 20, 2026Jun 4, 2026
traded Jan 20, 2026
+135dSEC Form 4

Evidence